Ambry Genetics Overview
- Founded
- 1999

- Status
- Acquired/Merged
- Employees
- 600

- Latest Deal Type
- M&A
- Financing Rounds
- 1
- Investments
- 1
Ambry Genetics General Information
Description
Operator of a genetics diagnostics company designed to provide a comprehensive suite of genetic testing applications for inherited and non-inherited diseases. The company's services include gene testing, classification & sequencing and conducting scientific research studies by collaborating with clinicians, patients and researchers, thus enabling the sharing of anonymized patient records with the global medical research community to fulfill the promise of the human genome to cure or manage human disease.
Contact Information
(Operating Subsidiary)
- 1 Enterprise
- Aliso Viejo, CA 92656
- United States
Ambry Genetics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Ambry Genetics‘s full profile, request access.
Request a free trialAmbry Genetics Comparisons
Industry
000000
000000 0
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAmbry Genetics Competitors (23)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
GeneDx | Corporate Backed or Acquired | Gaithersburg, MD | 000 | 000000&0 | ||
000000 000000 | Venture Capital-Backed | South Plainfield, NJ | 00 | 000000000 - | ||
0000000000 | Venture Capital-Backed | Dublin, Ireland | 000 | 0000000000 0 | ||
00000000 | Formerly PE-Backed | Paterna, Spain | 000 | 000000&0 | ||
000000000 | Private Equity-Backed | Foster City, CA | 000 | 00000 | 0000000 0000 | 00000 |
Ambry Genetics Patents
Ambry Genetics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20200294618-A1 | Method to perform medical procedures on breast cancer patients guided by an snp derived polygenic risk score | Pending | 12-Mar-2019 | 0000000000 | |
US-20140088942-A1 | Molecular genetic diagnostic system | Abandoned | 27-Sep-2012 | 000000000 | 0 |
EP-2901152-A4 | Molecular genetic diagnostic system | Withdrawn | 27-Sep-2012 | 000000000 | 0 |
EP-2901152-A1 | Molecular genetic diagnostic system | Withdrawn | 27-Sep-2012 | 000000000 | |
US-20030235834-A1 | Diagnosing respiratory disorders via presence of allelic aberrations in cystic fibrosis transmembrane conductance regulator (cftr) gene; restriction fragment length polymorphisms | Granted | 12-Nov-1999 | C12Q1/6883 | 00 |
Ambry Genetics Executive Team (10)
Ambry Genetics Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
00000000 00000 | Ambry Genetics | Chairman | 000 0000 |
Ambry Genetics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAmbry Genetics Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 00000 | 01-Apr-2015 | 0000000000 | Enterprise Systems (Healthcare) | 0000000 0 |
Ambry Genetics Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
0000000 00000000 | Enterprise Systems (Healthcare) | Delray Beach, FL | 0000 |